IRIS
ORLANDI, ESTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.072
AS - Asia 2.037
EU - Europa 1.232
SA - Sud America 294
Continente sconosciuto - Info sul continente non disponibili 126
AF - Africa 75
OC - Oceania 6
Totale 6.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.901
SG - Singapore 590
CN - Cina 488
HK - Hong Kong 355
IT - Italia 317
RU - Federazione Russa 255
VN - Vietnam 228
BR - Brasile 206
DE - Germania 160
BD - Bangladesh 147
FR - Francia 137
GB - Regno Unito 114
IE - Irlanda 65
IN - India 62
CA - Canada 60
MX - Messico 58
FI - Finlandia 40
ZA - Sudafrica 37
AR - Argentina 33
JP - Giappone 29
PL - Polonia 22
TR - Turchia 22
NL - Olanda 20
AT - Austria 17
IQ - Iraq 17
SE - Svezia 16
BE - Belgio 15
CO - Colombia 15
ES - Italia 12
PK - Pakistan 12
VE - Venezuela 12
ID - Indonesia 11
MY - Malesia 11
EC - Ecuador 10
JM - Giamaica 10
IL - Israele 8
SA - Arabia Saudita 8
TN - Tunisia 8
CR - Costa Rica 7
PT - Portogallo 7
SV - El Salvador 7
CL - Cile 6
DZ - Algeria 6
EG - Egitto 6
JO - Giordania 6
UA - Ucraina 6
UZ - Uzbekistan 6
AU - Australia 5
HN - Honduras 5
LV - Lettonia 5
PH - Filippine 5
PR - Porto Rico 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
KE - Kenya 4
MA - Marocco 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
QA - Qatar 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
CH - Svizzera 2
GP - Guadalupe 2
GT - Guatemala 2
HR - Croazia 2
HT - Haiti 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AL - Albania 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
FJ - Figi 1
GE - Georgia 1
GF - Guiana Francese 1
GR - Grecia 1
IM - Isola di Man 1
KH - Cambogia 1
Totale 6.708
Salva come PNG Salva come JPEG
Città #
San Jose 534
Dallas 509
Hong Kong 344
Council Bluffs 339
Singapore 274
Ashburn 178
Beijing 137
Lauterbourg 93
Los Angeles 88
Santa Clara 77
Ho Chi Minh City 74
Dublin 65
Redondo Beach 65
New York 62
Hanoi 61
Munich 50
Boardman 44
Milan 44
Moscow 44
Mexico City 42
Columbus 41
Falkenstein 40
Buffalo 38
Chandler 35
Johannesburg 30
Rome 27
Orem 26
Shanghai 26
Montreal 25
Pavia 25
Tokyo 25
Atlanta 22
Brooklyn 21
Helsinki 21
Phoenix 21
São Paulo 21
Warsaw 20
London 18
Turku 16
Changsha 15
Denver 15
Frankfurt am Main 15
Secaucus 15
Brussels 14
Nuremberg 14
Brasília 13
Seattle 13
Stockholm 13
Naples 12
Turin 12
Boston 11
Chennai 11
Chicago 11
Da Nang 11
Haiphong 11
Princeton 11
Florence 10
Guangzhou 10
Düsseldorf 9
Belo Horizonte 8
Charlotte 8
Dhaka 8
Houston 8
Lawrence 8
Manchester 8
Medford 8
Wilmington 8
Ankara 7
Bari 7
Kingston 7
Kuala Lumpur 7
Toronto 7
Amman 6
Ann Arbor 6
Baghdad 6
Elk Grove Village 6
Figino 6
Guayaquil 6
Hyderabad 6
Istanbul 6
Jacksonville 6
Medellín 6
Nanjing 6
Poplar 6
Rio de Janeiro 6
San Francisco 6
San José 6
Tashkent 6
Vienna 6
Buccinasco 5
Bến Tre 5
Hải Dương 5
Mumbai 5
Paris 5
Pittsburgh 5
Porto Alegre 5
Riga 5
Riyadh 5
San Salvador 5
Addis Ababa 4
Totale 4.123
Salva come PNG Salva come JPEG
Nome #
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area 301
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 145
Using the photon isoeffective dose formalism to compare and combine BNCT and CIRT in a head and neck tumour 122
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 115
Intravoxel incoherent motion as a tool to detect early microstructural changes in meningiomas treated with proton therapy 110
Cancer Rehabilitation and Physical Activity: the "Oncology in Motion" Project 106
Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations 103
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients 100
Contouring of the Pharyngeal Superior Constrictor Muscle (PSCM). A cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group 98
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 95
Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation 94
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 93
Radiomics and dosiomics for predicting local control after carbon-ion radiotherapy in skull-base chordoma 90
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 89
A Patient Selection Approach Based on NTCP Models and DVH Parameters for Definitive Proton Therapy in Locally Advanced Sinonasal Cancer Patients 88
Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy 87
An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia 85
To a new normal in radiation oncology: looking back and planning forward 84
Evaluation of endocrinological sequelae following particle therapy performed on anterior skull base lesions in the adult population 83
Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy 83
Charged particle radiotherapy for thyroid cancer. A systematic review 81
NR4A3 fusion molecular profile change pathological diagnosis? A case report 80
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients 78
Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? 78
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients 74
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review 74
Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation 73
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 73
Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy 72
The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment 72
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 72
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 71
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 69
Quality of life changes over time and predictors in a large head and neck patients’ cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study—a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 69
Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review 68
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 66
Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936) 65
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm? 65
Baseline MRI-radiomics can predict overall survival in non endemic nasopharyngeal cancer patients 64
A Dosiomics Analysis Based on Linear Energy Transfer and Biological Dose Maps to Predict Local Recurrence in Sacral Chordomas after Carbon-Ion Radiotherapy 63
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group 62
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC) 61
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) 60
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? 58
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 58
Current practice in proton therapy delivery in adult cancer patients across Europe 57
Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations 57
Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed 57
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 56
Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy? 55
Are there any dosimetric predictors of acute toxicity during RT for NPC that can be modulated by genetic risk factors? 55
Neutron brachytherapy in the modern era: Indications and evidence 55
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group 54
Sexual Health Dysfunction After Radiotherapy for Gynecological Cancer: Role of Physical Rehabilitation Including Pelvic Floor Muscle Training 54
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 54
Moderately accelerated intensity-modulated radiation therapy using simultaneous integrated boost: Practical reasons or evidence-based choice? A critical appraisal of literature 53
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 53
Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC) 53
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 53
Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era 53
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 52
Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma 52
How can we address the challenge of distant metastases in HNSCC prognosis? 51
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 51
Particle Radiotherapy for Skull Base Chondrosarcoma: A Clinical Series from Italian National Center for Oncological Hadrontherapy 51
The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer: Inter-fraction robustness in CIRT for pancreatic cancer 51
The Role of Carbon Ion Therapy in the Changing Oncology Landscape—A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy 49
Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision 49
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 48
Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series 48
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 47
Synthetic CT in Carbon Ion Radiotherapy of the Abdominal Site 47
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 47
Resection of the internal carotid artery in selected patients affected by cancer of the skull base 46
In Silico Feasibility Study of Carbon Ion Radiotherapy With Simultaneous Integrated Boost for Head and Neck Adenoid Cystic Carcinoma 45
Towards a European prospective data registry for particle therapy 44
Radiotherapy and Medical Treatment 44
How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy: RBE and LET in carbon ion therapy for sacral chordoma 43
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 43
Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity 43
A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 43
Lower-Neck Sparing Using Proton Therapy in Patients with Uninvolved Neck Nasopharyngeal Carcinoma: Is It Safe? 42
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 42
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 41
Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review 41
Repeatability and reproducibility of MRI‐radiomic features: A phantom experiment on a 1.5 T scanner 41
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy 41
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences? 41
The MUSES∗: a prognostic study on 1360 patients with sinonasal cancer undergoing endoscopic surgery-based treatment 40
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS 39
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 39
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 38
Current management and future challenges in salivary glands cancer 38
INDUCTION CHEMOTHERAPY WITHIN A MULTIMODALITYREATMENT OF NASAL CAVITY AND ETHMOID SINUS MALIGNANT EPITHELIAL TUMOURS: REPORT OF AN HOMOGENEOUS SERIES OF PATIENTS 38
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 38
Patterns of Failure after Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy for Patients with Nasopharyngeal Carcinoma 38
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design 38
Repeatability and reproducibility of MRI-radiomic features: A phantom experiment on a 1.5 T scanner 37
Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation 37
Clinical Insight on Proton Therapy for Paediatric Rhabdomyosarcoma 37
Totale 6.456
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.237
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202242 0 0 0 3 0 2 1 3 4 3 4 22
2022/2023153 16 9 4 5 4 13 15 4 67 1 9 6
2023/2024107 8 9 3 8 7 14 6 16 3 2 19 12
2024/20251.345 11 25 10 10 10 103 211 116 318 56 107 368
2025/20264.101 265 555 287 409 387 130 587 174 368 376 362 201
2026/20271.064 155 287 224 398 0 0 0 0 0 0 0 0
Totale 6.842